Granahan Investment Management, LLC Maxcyte, Inc. Transaction History

Granahan Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.6 - $5.24 $1.42 Million - $2.87 Million	-547,398 Reduced 27.7%	1,428,449 $6.71 Million
Q3 2023 Nov 14, 2023	BUY	$3.02 - $5.1 $253,556 - $428,190	83,959 Added 4.44%	1,975,847 $6.16 Million
Q2 2023 Aug 14, 2023	BUY	$3.69 - $5.35 $4.37 Million - $6.33 Million	1,183,731 Added 167.16%	1,891,888 $8.68 Million
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $128,424 - $187,696	31,867 Added 4.71%	708,157 $3.51 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $7.4 $2.84 Million - $4.28 Million	578,089 Added 588.68%	676,290 $3.69 Million

Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $443,868 - $639,288	98,201 New	98,201 $638,000

126

62M

2.4K

2.1K

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $412M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.